Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: First report by the WHO-GARD survey group

International Journal of COPD

Volumn 8, Issue , 2013, Pages 473-482

  Mohammad, Yousser ^a   Shaaban, Rafea ^a   Al Zahab, Bassam Abou ^b   Khaltaev, Nikolai ^c   Bousquet, Jean ^d,e   Dubaybo, Basim ^f  

^a TISHREEN UNIVERSITY   (Syrian Arab Republic)

^b Ministry of Health   (Syrian Arab Republic)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Behavior; COPD; Narghile; Passive smoking; Water pipe; Women

Indexed keywords

BRONCHODILATING AGENT; TOBACCO SMOKE;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CULTURAL ANTHROPOLOGY; DATA EXTRACTION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL DEVICE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NARGHILE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PASSIVE SMOKING; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SMOKING; SPIROMETRY; SYRIAN ARAB REPUBLIC; TABOO;

ASTHMA; BEHAVIOR; COPD; NARGHILE; PASSIVE SMOKING; WATER PIPE; WOMEN;

ADOLESCENT; ADULT; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; LUNG; MIDDLE AGED; ODDS RATIO; PREVALENCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; SMOKING; SPIROMETRY; SYRIA; TOBACCO SMOKE POLLUTION; VITAL CAPACITY; WOMEN'S HEALTH SERVICES; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84885049736     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S50551     Document Type: Article

References (50)

1. Global initiative for chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2013. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed June 23, 2013.
2. Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007;62:216-223.
3. Doseman JA, Cockroft D. Medical Clinics of North America: Obstructive Lung Disease, Part 1. Chronic Obstructive Pulmonary Disease. Vol 80. Philadelphia: WB Saunders; 1996.
4. Siroux V, Boudier A, Bousquet J, etal. Phenotypic determinants of uncontrolled asthma. J Allergy Clin Immunol. 2009;124:681-687.
5. Antó JM, Pinart M, Akdis M, etal. Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol. 2012;129:943-951.
6. Trédaniel J, Savinelli F, Vignot S, Bousquet G, Le Maignan C, Misset JL. Conséquences du tabagisme passif chez l'adulte. [The consequences of passive smoking in adults]. Rev Mal Respir. 2010;23:4S67-4S73. French.
7. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2011. Available from: http://www.ginasthma.org/documents/4. Accessed July 28, 2012.
8. United States Surgeon General. The health consequences of involuntary exposure to tobacco smoke. 2006. Available from: http://www.surgeongeneral.gov/library/reports/secondhandsmoke/factsheet1.html. Accessed August 17, 2013.
9. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med. 2004;10:98-103.
10. Ohar J, Fromer L, Donohue JF. Reconsidering sex-based stereotypes of COPD. Prim Care Respir J. 2011;20:370-378.
11. Haglund M. Women: the second wave of the tobacco epidemic. In: Lu R, Mackay J, Niu S, Peto R, editors. Tobacco: The Growing Epidemic. Proceedings of the Tenth World Conference on Tobacco or Health, 24-28 August 1997, Beijing, People's Republic of China. Heidelberg: Springer; 1997:18-20.
12. Martins P, Rosado-Pinto J, do Céu Teixeira M, etal. Under-report and underdiagnosis of chronic respiratory diseases in an African country. Allergy. 2009;64:1061-1067.
13. Russell R, Anzueto A, Weisman I. Optimizing management of chronic obstructive pulmonary disease in the upcoming decade. Int J Chron Obstruct Pulmon Dis. 2011;6:47-61.
14. van Gemert F, van der Molen T, Jones R, Chavannes N. The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J. 2011;20:240-248.
15. [No authors listed]. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax. 1997;52 Suppl 5:S1-S28.
16. Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma (GINA) program. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy. 2004;59:469-478.
17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5-40.
18. Mohammad Y, Kakah M, Mohammad Y. Chronic respiratory effect of narguileh smoking compared to cigarette smoking in women from the east Mediterranean region. Int J COPD. 2008;3:405-414.
19. Ward KD, Eissenberg T, Rastam S, etal. The tobacco epidemic in Syria. Tob Control. 2006;15 Suppl 1:i24-i29.
20. Riachy M, Rehayem C, Khoury C, etal. Les fumeurs de narghilé sont-ils différents des fumeurs de cigarettes? [Are narghile smokers different from cigarette smokers?]. Rev Mal Respir. 2008;25:313-318. French.
21. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health, assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000;117: 1146-1161.
22. Miller MR, Crapo R, Hankinson J, etal. Standardisation of spirometry. Eur Respir J. 2005;26:319-338.
23. Pellegrino R, Viegi G, Brusasco V, etal. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-968.
24. Maziak W, Essenberg T, Rastam S, etal. Beliefs and attitudes related to narghile (waterpipe) smoking among university students in Syria. Ann Epidemiol. 2004;14:646-654.
25. Aghi MB. Tobacco and the Indian woman. In: Lu R, Mackay J, Niu S, Peto R, editors. Tobacco: The Growing Epidemic. Proceedings of the Tenth World Conference on Tobacco or Health, 24-28 August 1997, Beijing, People's Republic of China. Heidelberg: Springer; 1997: 231-233.
26. Bilir N, Yyldyz BA. Influence of sex on smoking behavior in Turkey. In: Lu R, Mackay J, Niu S, Peto R, editors. Tobacco: The Growing Epidemic. Proceedings of the Tenth World Conference on Tobacco or Health, 24-28 August 1997, Beijing, People's Republic of China. Heidelberg: Springer; 1997:234-235.
27. Raad D, Gaddam S, Schunemann HJ, etal. Effect of water pipe tobacco smoking on lung function: a systematic review and meta-analysis. Chest. 2011;139:764-774.
28. Menezes AM, Perez-Padilla R, Jardim JR, etal. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875-1881.
29. Weiss T, Mark JU, Jonathan MS. Environmental tobacco smoke exposure and asthma in adults. Environ Health Perspect. 1999;107 Suppl 6:891-895.
30. Chaouachi K. Hookah (shisha, narghile) smoking and environmental tobacco smoke (ETS). A critical review of the relevant literature and the public health consequences. Int J Environ Res Public Health. 2009;6:798-843.
31. Masi MA, Hanley JA, Ernst P, Becklake MR. Environmental exposure to tobacco smoke and lung function in young adults. Am Rev Respir Dis. 1988;138:296-299.
32. Masjedi MR, Kazemi H, Johnson DC. Effects of passive smoking on the pulmonary function of adults. Thorax. 1990;45:27-31.
33. Mohammad Y, Tabbah K, Mohammad S, Yassine F, Clayton T, Hassan M. International study of asthma and allergies in childhood: phase 3 in the Syrian Arab Republic. East Mediterr Health J. 2010;16:710-716.
34. Mohammad Y, Myers D. Questionnaire study of self reported asthma triggers: a case series of east Mediterranean Syrian patients. Pak J Chest Med. 2007;13:3-10.
35. Gilliland FD, Islam T, Berhane K, etal. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med. 2006;174: 1094-1100.
36. Baena-Cagnani CE, Gómez RM, Baena-Cagnani R, Canonica GW. Impact of environmental tobacco smoke and active tobacco smoking on the development and outcomes of asthma and rhinitis. Curr Opin Allergy Clin Immunol. 2009;9:136-140.
37. Hancox RJ, Welch D, Poulton R, etal. Cigarette smoking and allergic sensitization: a 32-year population-based cohort study. J Allergy Clin Immunol. 2008;121:38-42.
38. Mitchell EA, Beasley R, Keil U, Montefort S, Odhiambo J. The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from Phase Three of the ISAAC programme. Thorax. 2012;67:941-949.
39. Bouzigon E. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med. 2008;359:1985-1994.
40. Pastukh VM, Zhang L, Ruchko MV, etal. Oxidative DNA damage in lung tissue from patients with COPD is clustered in functionally significant sequences. Int J Chron Obstruct Pulmon Dis. 2011;6:209-217.
41. Floreani AA, Rennard SI. The role of cigarette smoke in the pathogenesis of asthma and as trigger of acute symptoms. Curr Opin Pulm Med. 1999;5:38-46.
42. Feleszko W, Zawadzka-Krajewska A, Matysiak K, etal. Parental tobacco smoking is associated with augmented IL-13secretion in children with allergic asthma. J Allergy Clin Immunol. 2006;117:97-102.
43. Wirth N, Bohadana A, Spinosa S, Martinet Y. Les pathologies respiratoires liée au tabagisme passif. [Respiratory diseases related to passive smoking]. Rev Mal Respir. 2009;26:10-16. French.
44. Global initiative for chronic Obstructive Lung Disease. GOLD spirometry guide. 2010. Available from: http://www.goldcopd.org/other-resources-gold-spirometry-guide.html. Accessed August 2, 2013.
45. World Health Organization. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva: WHO; 2010. Available from: http://whqlibdoc.who.int/publications/2010/9789241598996_eng.pdf. Accessed August 17, 2013.
46. World Health Organization. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Geneva: WHO; 2009. Available from: http://www.who.int/nmh/publications/9789241597418/en/index.html. Accessed August 17, 2013.
47. Bousquet J, Kiley J, Bateman ED, etal. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J. 2010;36:995-1001.
48. Yusuf MO. Systems for the management of respiratory disease in primary care-an international series: Pakistan. Prim Care Respir J. 2009;18:3-9.
49. Chiang CY, Billo NE, Enarson DA. World Spirometry Day: intention to test should be intention to treat. Public Health Action. 2012;2:30.
50. World Health Organization. Global Alliance against Chronic Respiratory Diseases (GARD): 6th General Meeting, 23-24 September 2011, Warsaw, Poland. Geneva: WHO; 2012. Available from: http://www.who.int/gard/publications/GARDGAWarsaw2011.pdf. Accessed August 18, 2013.